Skip to main content

Zolpidem News

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Including Ambien, Ambien CR, Edluar, and Zolpimist  [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public that FDA has approved label changes specifying new ...

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Including Ambien, Ambien CR, Edluar, and Zolpimist    [Posted 01/10/2013] ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that ...

FDA Approves Intermezzo for Middle-of-the-Night Waking Followed by Difficulty Returning to Sleep

November 23, 2011 – The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Insomnia

Related drug support groups

Ambien

Zolpidem patient information at Drugs.com